Milestone payments upon achievement of certain clinical, regulatory and sales milestone events
Denali Therapeutics Inc.·Products & Services·1 segment
Breakdown
Segments
Peripheral Program LicenseView metric
| Segment | Q1 '26 |
|---|---|
| Peripheral Program License | $495M |
| Total | $495M |